Once again, thanks for tuning in. Holly Shields here for Kalkine Media. Combining COVID-19 and flu protection in one vaccine is a novel concept that Moderna and Novavax have adopted.
*Biologics License Application, Moderna finished the rolling submission course for its COVID-19 vaccine in the US.
*The Combination vaccine candidate blends Moderna’s COVID-19 vaccine plus flu vaccine candidate.
*The trial would assess the safety, tolerance power & immune reaction to NanoFlu formulated along with NVX-CoV2373 & Matrix-M adjuvant in 640 healthy people between 50 years to 70 years.
*Both Covid-19 and Influenza have proved themselves deadly with people losing their lives. A combined vaccine fills the gap of not protecting infections like COVID-19
*Similarly, for Moderna, the company’s COVID-19 vaccine played a pivotal role in minimising hospitalizations, and deaths. This has helped Moderna get ranked as the top healthcare company, gaining No.